Reduction in blood product usage associated with routine use of mini bypass systems in extracorporeal circulation

Abstract

Objective: The objective of this study is to investigate the hypothesis that a reduced prime extracorporeal circulation (ECC) system and ensuing reduction in patient hemodilution can affect blood product use. Methods: We performed a prospective, randomized study from a group of 60 consecutive coronary artery bypass graft (CABG) patients, comparing blood product usage and postoperative bleeding in 30 mini bypass systems (n = 30) to 30 conventional systems (n = 30). The patient demographics in terms of patient weight, height, age, preoperative hemoglobin, preoperative hematocrit, BSA, ejection fraction, and NYHA were not statistically significant. Results: Blood product use, including fresh frozen plasma (FFP) and homolgous blood transfusions was tracked through the operating theater and into the intensive care unit. In the mini bypass group, while no homologous blood transfusions were given in the OR, 27% of the patients received at least one unit of homolgous blood. In the control group, 43% of the patients received at least one unit of blood in the OR or in the ICU and there was a stastistically-significant 38% reduction in homologous blood product use (p = 0.05). For the patients who received homologous blood, there was also a significant reduction in transfused volume (0.53±0.90 units blood mini bypass vs 1.3±1.93 units conventional, p <0.05). In terms of FFP, there was also a stastistically significant difference between the two groups (0 units transfused in mini bypass group vs 3 patients receiving one unit FFP in the control group, p<0.001). Cumulative postoperative bleeding during the ICU stay was also evaluated, yielding a significant reduction (365±495 ml mini bypass vs 825± 975 ml conventional, p <0.05). Conclusion: Mini bypass reduces on-pump hemodilution and, therefore, donor blood usage in routine CABG patients as compared to conventional ECC circuits and can reduce postoperative bleeding as compared to a traditional system. The mini bypass system is safe in routine clinical use and can manage easily the same number of anastomoses as a traditional system and should be considered a favorable alternative to conventional ECC in all revascularization cases. Perfusion (2007) 22, 9-14.

Get full access to this article

View all access options for this article.

References

Panico FG , Neptune WB A mechanism to eliminate the donor blood prime from the pump oxygenator. Surg Forum 1959; 10: 605-609.

Chandler W. Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2005 Aug; 19(4): 459-67.

Swaminathan M. , Phillips-Bute BG , Conlon PJ , Smith PK , Newman MF , Stafford-Smith M. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003 ; 76: 784-91.

Habib R. , Zacharias A. , Schwann TA , Riordan CJ , Durham SJ , Shah A.

Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should the current practice be changed?

J Thorac Cardiovasc Surg 2003; 125: 1438-50.

Groom R. High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question . Perfusion 2001; 16: 339-43.

Engoren MC , Habib RH , Zacharias A. , Schwann TA , Riordan CJ , Durham SJ Effect of blood transfusion on long term survival after cardiac operation . Ann Thorac Surg 2002; 74: 1180-6.

Zindrou D. , Taylor KM , Bagger JP Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery. Lancet 2002; 359: 1747-48.

Mezzetti A. , Calafiore AM , Lapenna D. , et al. Intermittent antegrade warm blood cardioplegia reduces oxidative stress and improves metabolism of the ischemic reperfused human myocardium . J Thorac Cardiovasc Surg 1995; 109: 787-95.

Albes JM , Sköhr IM , Kaluza M. , et al. Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating. J Thorac Cardiovasc Surg 2003; 126: 1504-12.

10.

De Somer F. , Van Belleghem Y. , Caes F. , et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion 2002 Jan; 17: 39-44.

11.

Harig F. , Maier C. , Hakami L. , et al. Phosphorylcholinecoated cardiopulmonary bypass improves biocompatibility: reduced contact activation and endothelin-1 release. Crit Care 2001; 5 (Supp B): 14.

12.

Wippermann J. , Albes JM , Hartrumpf M. , et al. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off pump technique in CABG patients: selected parameters of coagulation and inflammatory system. Eur J Cardiothorac Surg 2005; 28: 127-32.

13.

Fromes Y. , Gaillard D. , Ponzio O. , et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002; 22: 527-33.

14.

Vaislic C. , Bical O. , Farge C. , et al. Totally minimized extracorporeal circulation: an important benefit for coronary artery bypass grafting in Jehovah's witnesses. Heart Surg Forum 2003; 6(5): 307-10.

15.

Wiesenack C. Four years' experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 2004; 28(12): 1082-88.

16.

Remadi JP , Rakotoarivelo Z. , Marticho P. , Benamar A. Prospective randomized study comparing coronary artery bypass grafting with the new mini-extracorporeal circulation (Jostra MECC System) or with a standard cardiopulmonary bypass. Am Heart J 2006; 151(1): 198.

17.

Folliguet TA , Villa E. , Vandeneyden F. , Laborde F. Coronary artery bypass graft with minimal extracorporeal circulation. Heart Surg Forum 2003; 6(5): 297301.

18.

Huybregts R. , Veerman D. , Vonk A. , et al. First clinical experience with the air purge control and electrical remote-controlled clamp in mini bypass. Artif Organs 2006; 30(9). 721-24.

19.

Schonberger JP , Everts PA , Hoffmann JJ Systemic blood activation with open and closed venous reservoirs. Ann Thorac Surg 1995 Jun; 59(6): 1549-55.